PCSK9 inhibitors in the management of atherosclerotic cardiovascular disease: Current clinical trials and future directions

被引：0
|
作者：
Nie, Wenyi [1 ]
Yue, Yingbin [2 ,3 ]
Hu, Jingqing [1 ]
机构：
[1] Changchun Univ Chinese Med, Changchun 130117, Peoples R China
[2] Xinjiang Med Univ, Affiliated Hosp 1, Urumqi 830054, Peoples R China
[3] Xinjiang Med Univ, State Key Lab Pathogenesis, Prevent & Treatment High Incidence Dis Cent Asia, Urumqi 830054, Peoples R China
来源：
ATHEROSCLEROSIS | 2024年 / 399卷
基金：
国家重点研发计划;
关键词：
PCSK9; inhibitors; Clinical trial; Existing evidence; Future perspectives;
D O I：
10.1016/j.atherosclerosis.2024.119043
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] The Pharmacologic Role and Clinical Utility of PCSK9 Inhibitors for the Treatment of Hypercholesterolemia
    White, C. Michael
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2018, 23 (04) : 301 - 308
  • [32] The PCSK9 Inhibitors: A Novel Therapeutic Target Enters Clinical Practice
    Lepor, Norman E.
    Kereiakes, Dean J.
    AMERICAN HEALTH AND DRUG BENEFITS, 2015, 8 (09)
  • [33] PCSK9 Inhibitors: From Nature's Lessons to Clinical Utility
    Raal, Frederick J.
    Chilton, Robert
    Ranjith, Naresh
    Rambiritch, Virendra
    Leisegang, Rory F.
    Ebrahim, Iftikhar O.
    van Tonder, Alet
    Shunmoogam, Nelusha
    Bouharati, Celia
    Musa, Moji G.
    Karamchand, Sumanth
    Naidoo, Poobalan
    Blom, Dirk J.
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2020, 20 (06) : 840 - 854
  • [34] Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors, Reality or Dream in Managing Patients with Cardiovascular Disease
    Alkhalil, Mohammad
    CURRENT DRUG METABOLISM, 2019, 20 (01) : 72 - 82
  • [35] Statins and PCSK9 inhibitors: What is their role in coronavirus disease 2019?
    Barkas, Fotios
    Milionis, Haralampos
    Anastasiou, Georgia
    Liberopoulos, Evangelos
    MEDICAL HYPOTHESES, 2021, 146
  • [36] Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the human atherosclerotic plaque
    Marfella, Raffaele
    Prattichizzo, Francesco
    Sardu, Celestino
    Paolisso, Pasquale
    D'Onofrio, Nunzia
    Scisciola, Lucia
    La Grotta, Rosalba
    Frige, Chiara
    Ferraraccio, Franca
    Panarese, Iacopo
    Fanelli, Mara
    Modugno, Piero
    Calafiore, Antonio Maria
    Melchionna, Mario
    Sasso, Ferdinando Carlo
    Furbattoj, Fulvio
    D'Andreaj, Davide
    Siniscalchi, Mario
    Mauro, Ciro
    Cesaro, Arturo
    Calabro, Paolo
    Santulli, Gaetano
    Balestrieri, Maria Luisa
    Barbato, Emanuele
    Ceriello, Antonio
    Paolisso, Giuseppe
    ATHEROSCLEROSIS, 2023, 378
  • [37] PCSK9 and Lipid Metabolism: Genetic Variants, Current Therapies, and Cardiovascular Outcomes
    Grejtakova, Daniela
    Boronova, Iveta
    Bernasovska, Jarmila
    Bellosta, Stefano
    CARDIOVASCULAR DRUGS AND THERAPY, 2024,
  • [38] Appropriate Use of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors for Atherosclerotic Cardiovascular Disease: Comparison of Recommendations from Different Guidelines or Consensus Around the World
    Lin, Jia-Ling
    Huang, Po-Hsun
    Yeh, Hung-, I
    Li, Yi-Heng
    ACTA CARDIOLOGICA SINICA, 2020, 36 (05) : 403 - 408
  • [39] A Systematic Review on the Safety and Efficacy of PCSK9 Inhibitors in Lowering Cardiovascular Risks in Patients With Chronic Kidney Disease
    Igweonu-Nwakile, Emmanuelar O.
    Ali, Safina
    Paul, Salomi
    Yakkali, Shreyas
    Selvin, Sneha Teresa
    Thomas, Sonu
    Bikeyeva, Viktoriya
    Abdullah, Ahmed
    Radivojevic, Aleksandra
    Abu Jad, Anas A.
    Ravanavena, Anvesh
    Ravindra, Chetna
    Balani, Prachi
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (09)
  • [40] Cost-effectiveness analysis of PCSK9 inhibitors in cardiovascular diseases: a systematic review
    Azari, Samad
    Rezapour, Aziz
    Omidi, Negar
    Alipour, Vahid
    Behzadifar, Masoud
    Safari, Hossein
    Tajdini, Masih
    Bragazzi, Nicola Luigi
    HEART FAILURE REVIEWS, 2020, 25 (06) : 1077 - 1088
12345